In this report, the Asia-Pacific Drug Eluting Stents (DES) Market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.
A drug-eluting stent (DES) is usually placed within the peripheral or coronary artery during an angioplasty procedure.
Increasing prevalence of coronary artery disease and other cardiovascular diseases is expected to boost growth of Asia Pacific drug-eluting stents market over the forecast period. For instance, according to the study ‘Divergent trends in ischaemic heart disease and stroke mortality in India from 2000 to 2015: a nationally representative mortality study’, published in the journal Lancet in August 2018, heart ailments caused more than 2.1 million deaths in India in 2015 at all ages. Moreover, 0.9 million deaths were caused by coronary heart disease and 0.4 million by stroke.
DES are superior to bare metal stents in saphenous vein grafts, which is also expected to boost their adoption, thereby propelling growth of the market. DES is preferred to bare metal stent for elective and emergency percutaneous coronary intervention, owing to the ability of DES to reduce major adverse cardiac events in native coronary artery disease.
However, availability of alternatives such as medical therapy and coronary artery bypass grafting is expected to hinder growth of the market. Moreover, use of DES may lead to clot thrombosis formation, which is also expected to limit adopting of DESs.
The demand for biodegradable polymer DES is increasing compared to second-generation polymer drug-eluting. Biodegradable polymer DES offers long-term outcomes compared with a second-generation durable polymer drug-eluting stent during percutaneous coronary intervention for the treatment of patients with acute myocardial infarction.
Major players in the market are focused on conducting clinical trials to expand their product portfolio. For instance, in November 2019, Boston Scientific announced positive data for Eluvia Drug-Eluting Vascular Stent for the treatment of femoropopliteal disease.
In July 2019, SINOMED completed enrollment in the PIONEER III randomized, controlled clinical trial to assess the safety and effectiveness of the BuMA Supreme DES in order to obtain key regulatory approvals for the BuMA Supreme Drug-Eluting Stent (DES) System.
Key Takeaways:
- Increasing prevalence of cardiovascular diseases is expected to augment growth of Asia Pacific drug-eluting stents market over the forecast period
- Use of DES may lead to clot thrombosis formation, which is expected to limit growth of the market
- Major players operating in Asia Pacific drug-eluting stents market include Abbott Vascular, Advantec Vascular, B. Braun Melsengen AG, Biosensors, Biotronik, Blue Medical, Boston Scientific, DISA Vascular, Essen, Medtronic Vascular, MicroPort Medical, MIV Therapeutics, Orbusneich, Promed Medical, Relisys Medical, Reva Medical, Sahajanand, Sino Medical, Sorin, and Terumo Medical
Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Drug Eluting Stents (DES) for these regions, from 2014 to 2025 (forecast), including
➟ China
➟ Japan
➟ South Korea
➟ Taiwan
➟ India
➟ Southeast Asia
➟ Australia
Asia-Pacific Drug Eluting Stents (DES) market competition by top manufacturers/players, with Drug Eluting Stents (DES) sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
➟ Abbott Vascular
➟ Advantec Vascular
➟ B.Braun Melsengen AG
➟ Biosensors
➟ Biotronik
➟ Blue Medical
➟ Boston Scientific
➟ DISA Vascular
➟ Essen
➟ Medtronic Vascular
➟ MicroPort Medical
➟ MIV Therapeutics
➟ Orbusneich
➟ Promed Medical
➟ Relisys Medical
➟ Reva Medical
➟ Sahajanand
➟ Sino Medical
➟ Sorin
➟ Terumo Medical
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
➟ Cobalt-chromium alloy Stents
➟ Magnesium alloy Stents
➟ Tyrosine polycarbonate Stents
➟ Nitinol Stents
➟ Platinum chromium alloy Stents
➟ Stainless steel Stents
➟ Other Materials
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Drug Eluting Stents (DES) for each application, including
➟ Coronary Heart Disease
➟ Clinical
▣ Note: If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Asia-Pacific Drug Eluting Stents (DES) Market Report 2019
1 Drug Eluting Stents (DES) Overview
1.1 Product Overview and Scope of Drug Eluting Stents (DES)
1.2 Classification of Drug Eluting Stents (DES) by Product Category
1.2.1 Asia-Pacific Drug Eluting Stents (DES) Market Size (Sales) Comparison by Types (2014-2025)
1.2.2 Asia-Pacific Drug Eluting Stents (DES) Market Size (Sales) Market Share by Type (Product Category) in 2018
1.2.3 Cobalt-chromium alloy Stents
1.2.4 Magnesium alloy Stents
1.2.5 Tyrosine polycarbonate Stents
1.2.6 Nitinol Stents
1.2.7 Platinum chromium alloy Stents
1.2.8 Stainless steel Stents
1.2.9 Other Materials
1.3 Asia-Pacific Drug Eluting Stents (DES) Market by Application/End Users
1.3.1 Asia-Pacific Drug Eluting Stents (DES) Sales (Volume) and Market Share Comparison by Applications (2014-2025)
1.3.2 Coronary Heart Disease
1.3.3 Clinical
1.4 Asia-Pacific Drug Eluting Stents (DES) Market by Region
1.4.1 Asia-Pacific Drug Eluting Stents (DES) Market Size (Value) Comparison by Region (2014-2025)
1.4.2 China Status and Prospect (2014-2025)
1.4.3 Japan Status and Prospect (2014-2025)
1.4.4 South Korea Status and Prospect (2014-2025)
1.4.5 Taiwan Status and Prospect (2014-2025)
1.4.6 India Status and Prospect (2014-2025)
1.4.7 Southeast Asia Status and Prospect (2014-2025)
1.4.8 Australia Status and Prospect (2014-2025)
1.5 Asia-Pacific Market Size (Value and Volume) of Drug Eluting Stents (DES) (2014-2025)
1.5.1 Asia-Pacific Drug Eluting Stents (DES) Sales and Growth Rate (2014-2025)
1.5.2 Asia-Pacific Drug Eluting Stents (DES) Revenue and Growth Rate (2014-2025)
2 Asia-Pacific Drug Eluting Stents (DES) Competition by Players/Suppliers, Region, Type and Application
2.1 Asia-Pacific Drug Eluting Stents (DES) Market Competition by Players/Suppliers
2.1.1 Asia-Pacific Drug Eluting Stents (DES) Sales Volume and Market Share of Key Players/Suppliers (2014-2019)
2.1.2 Asia-Pacific Drug Eluting Stents (DES) Revenue and Share by Players/Suppliers (2014-2019)
2.2 Asia-Pacific Drug Eluting Stents (DES) (Volume and Value) by Type
2.2.1 Asia-Pacific Drug Eluting Stents (DES) Sales and Market Share by Type (2014-2019)
2.2.2 Asia-Pacific Drug Eluting Stents (DES) Revenue and Market Share by Type (2014-2019)
2.3 Asia-Pacific Drug Eluting Stents (DES) (Volume) by Application
2.4 Asia-Pacific Drug Eluting Stents (DES) (Volume and Value) by Region
2.4.1 Asia-Pacific Drug Eluting Stents (DES) Sales and Market Share by Region (2014-2019)
2.4.2 Asia-Pacific Drug Eluting Stents (DES) Revenue and Market Share by Region (2014-2019)
3 China Drug Eluting Stents (DES) (Volume, Value and Sales Price)
3.1 China Drug Eluting Stents (DES) Sales and Value (2014-2019)
3.1.1 China Drug Eluting Stents (DES) Sales Volume and Growth Rate (2014-2019)
3.1.2 China Drug Eluting Stents (DES) Revenue and Growth Rate (2014-2019)
3.1.3 China Drug Eluting Stents (DES) Sales Price Trend (2014-2019)
3.2 China Drug Eluting Stents (DES) Sales Volume and Market Share by Type
3.3 China Drug Eluting Stents (DES) Sales Volume and Market Share by Application
4 Japan Drug Eluting Stents (DES) (Volume, Value and Sales Price)
4.1 Japan Drug Eluting Stents (DES) Sales and Value (2014-2019)
4.1.1 Japan Drug Eluting Stents (DES) Sales Volume and Growth Rate (2014-2019)
4.1.2 Japan Drug Eluting Stents (DES) Revenue and Growth Rate (2014-2019)
4.1.3 Japan Drug Eluting Stents (DES) Sales Price Trend (2014-2019)
4.2 Japan Drug Eluting Stents (DES) Sales Volume and Market Share by Type
4.3 Japan Drug Eluting Stents (DES) Sales Volume and Market Share by Application
5 South Korea Drug Eluting Stents (DES) (Volume, Value and Sales Price)
5.1 South Korea Drug Eluting Stents (DES) Sales and Value (2014-2019)
5.1.1 South Korea Drug Eluting Stents (DES) Sales Volume and Growth Rate (2014-2019)
5.1.2 South Korea Drug Eluting Stents (DES) Revenue and Growth Rate (2014-2019)
5.1.3 South Korea Drug Eluting Stents (DES) Sales Price Trend (2014-2019)
5.2 South Korea Drug Eluting Stents (DES) Sales Volume and Market Share by Type
5.3 South Korea Drug Eluting Stents (DES) Sales Volume and Market Share by Application
6 Taiwan Drug Eluting Stents (DES) (Volume, Value and Sales Price)
6.1 Taiwan Drug Eluting Stents (DES) Sales and Value (2014-2019)
6.1.1 Taiwan Drug Eluting Stents (DES) Sales Volume and Growth Rate (2014-2019)
6.1.2 Taiwan Drug Eluting Stents (DES) Revenue and Growth Rate (2014-2019)
6.1.3 Taiwan Drug Eluting Stents (DES) Sales Price Trend (2014-2019)
6.2 Taiwan Drug Eluting Stents (DES) Sales Volume and Market Share by Type
6.3 Taiwan Drug Eluting Stents (DES) Sales Volume and Market Share by Application
7 India Drug Eluting Stents (DES) (Volume, Value and Sales Price)
7.1 India Drug Eluting Stents (DES) Sales and Value (2014-2019)
7.1.1 India Drug Eluting Stents (DES) Sales Volume and Growth Rate (2014-2019)
7.1.2 India Drug Eluting Stents (DES) Revenue and Growth Rate (2014-2019)
7.1.3 India Drug Eluting Stents (DES) Sales Price Trend (2014-2019)
7.2 India Drug Eluting Stents (DES) Sales Volume and Market Share by Type
7.3 India Drug Eluting Stents (DES) Sales Volume and Market Share by Application
8 Southeast Asia Drug Eluting Stents (DES) (Volume, Value and Sales Price)
8.1 Southeast Asia Drug Eluting Stents (DES) Sales and Value (2014-2019)
8.1.1 Southeast Asia Drug Eluting Stents (DES) Sales Volume and Growth Rate (2014-2019)
8.1.2 Southeast Asia Drug Eluting Stents (DES) Revenue and Growth Rate (2014-2019)
8.1.3 Southeast Asia Drug Eluting Stents (DES) Sales Price Trend (2014-2019)
8.2 Southeast Asia Drug Eluting Stents (DES) Sales Volume and Market Share by Type
8.3 Southeast Asia Drug Eluting Stents (DES) Sales Volume and Market Share by Application
9 Australia Drug Eluting Stents (DES) (Volume, Value and Sales Price)
9.1 Australia Drug Eluting Stents (DES) Sales and Value (2014-2019)
9.1.1 Australia Drug Eluting Stents (DES) Sales Volume and Growth Rate (2014-2019)
9.1.2 Australia Drug Eluting Stents (DES) Revenue and Growth Rate (2014-2019)
9.1.3 Australia Drug Eluting Stents (DES) Sales Price Trend (2014-2019)
9.2 Australia Drug Eluting Stents (DES) Sales Volume and Market Share by Type
9.3 Australia Drug Eluting Stents (DES) Sales Volume and Market Share by Application
10 Asia-Pacific Drug Eluting Stents (DES) Players/Suppliers Profiles and Sales Data
10.1 Abbott Vascular
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Drug Eluting Stents (DES) Product Category, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Abbott Vascular Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2014-2019)
10.1.4 Main Business/Business Overview
10.2 Advantec Vascular
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Drug Eluting Stents (DES) Product Category, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Advantec Vascular Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2014-2019)
10.2.4 Main Business/Business Overview
10.3 B.Braun Melsengen AG
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Drug Eluting Stents (DES) Product Category, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 B.Braun Melsengen AG Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2014-2019)
10.3.4 Main Business/Business Overview
10.4 Biosensors
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Drug Eluting Stents (DES) Product Category, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Biosensors Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2014-2019)
10.4.4 Main Business/Business Overview
10.5 Biotronik
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Drug Eluting Stents (DES) Product Category, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Biotronik Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2014-2019)
10.5.4 Main Business/Business Overview
10.6 Blue Medical
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Drug Eluting Stents (DES) Product Category, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 Blue Medical Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2014-2019)
10.6.4 Main Business/Business Overview
10.7 Boston Scientific
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Drug Eluting Stents (DES) Product Category, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 Boston Scientific Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2014-2019)
10.7.4 Main Business/Business Overview
10.8 DISA Vascular
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Drug Eluting Stents (DES) Product Category, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 DISA Vascular Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2014-2019)
10.8.4 Main Business/Business Overview
10.9 Essen
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Drug Eluting Stents (DES) Product Category, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 Essen Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2014-2019)
10.9.4 Main Business/Business Overview
10.10 Medtronic Vascular
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Drug Eluting Stents (DES) Product Category, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 Medtronic Vascular Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2014-2019)
10.10.4 Main Business/Business Overview
10.11 MicroPort Medical
10.12 MIV Therapeutics
10.13 Orbusneich
10.14 Promed Medical
10.15 Relisys Medical
10.16 Reva Medical
10.17 Sahajanand
10.18 Sino Medical
10.19 Sorin
10.20 Terumo Medical
11 Drug Eluting Stents (DES) Manufacturing Cost Analysis
11.1 Drug Eluting Stents (DES) Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Drug Eluting Stents (DES)
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Drug Eluting Stents (DES) Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Drug Eluting Stents (DES) Major Manufacturers in 2018
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change
15 Asia-Pacific Drug Eluting Stents (DES) Market Forecast (2019-2025)
15.1 Asia-Pacific Drug Eluting Stents (DES) Sales Volume, Revenue and Price Forecast (2019-2025)
15.1.1 Asia-Pacific Drug Eluting Stents (DES) Sales Volume and Growth Rate Forecast (2019-2025)
15.1.2 Asia-Pacific Drug Eluting Stents (DES) Revenue and Growth Rate Forecast (2019-2025)
15.1.3 Asia-Pacific Drug Eluting Stents (DES) Price and Trend Forecast (2019-2025)
15.2 Asia-Pacific Drug Eluting Stents (DES) Sales Volume, Revenue and Growth Rate Forecast by Region (2019-2025)
15.2.1 Asia-Pacific Drug Eluting Stents (DES) Sales Volume and Growth Rate Forecast by Region (2019-2025)
15.2.2 Asia-Pacific Drug Eluting Stents (DES) Revenue and Growth Rate Forecast by Region (2019-2025)
15.2.3 China Drug Eluting Stents (DES) Sales, Revenue and Growth Rate Forecast (2019-2025)
15.2.4 Japan Drug Eluting Stents (DES) Sales, Revenue and Growth Rate Forecast (2019-2025)
15.2.5 South Korea Drug Eluting Stents (DES) Sales, Revenue and Growth Rate Forecast (2019-2025)
15.2.6 Taiwan Drug Eluting Stents (DES) Sales, Revenue and Growth Rate Forecast (2019-2025)
15.2.7 India Drug Eluting Stents (DES) Sales, Revenue and Growth Rate Forecast (2019-2025)
15.2.8 Southeast Asia Drug Eluting Stents (DES) Sales, Revenue and Growth Rate Forecast (2019-2025)
15.2.9 Australia Drug Eluting Stents (DES) Sales, Revenue and Growth Rate Forecast (2019-2025)
15.3 Asia-Pacific Drug Eluting Stents (DES) Sales, Revenue and Price Forecast by Type (2019-2025)
15.3.1 Asia-Pacific Drug Eluting Stents (DES) Sales Forecast by Type (2019-2025)
15.3.2 Asia-Pacific Drug Eluting Stents (DES) Revenue Forecast by Type (2019-2025)
15.3.3 Asia-Pacific Drug Eluting Stents (DES) Price Forecast by Type (2019-2025)
15.4 Asia-Pacific Drug Eluting Stents (DES) Sales Forecast by Application (2019-2025)
16 Research Findings and Conclusion
17 Appendix
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer
Request Discount 
Inquire Before Buy
